| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025741686 |
| P356 | DOI | 10.1038/35021239 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/35021239 |
| P698 | PubMed publication ID | 10963610 |
| P5875 | ResearchGate publication ID | 12357674 |
| P2093 | author name string | Hill AV | |
| Seder RA | |||
| P2860 | cites work | Virus-specific CD8+ T cells in primary and secondary influenza pneumonia | Q45755057 |
| Virus-specific CD8+ T-cell memory determined by clonal burst size | Q45789854 | ||
| Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. | Q46315215 | ||
| Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine | Q47837811 | ||
| Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers | Q47860884 | ||
| Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients | Q47918537 | ||
| Class II-independent generation of CD4 memory T cells from effectors. | Q52031200 | ||
| Following the development of a CD4 T cell response in vivo: from activation to memory formation. | Q52032084 | ||
| Antigen-specific development of primary and memory T cells in vivo. | Q52053475 | ||
| Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA | Q56930699 | ||
| Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells | Q57075707 | ||
| T cell memory | Q74578125 | ||
| Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients | Q77204398 | ||
| Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection | Q77658710 | ||
| DNA vaccines--designer vaccines for the 21st century | Q78021965 | ||
| CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma | Q24568172 | ||
| Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs | Q24644853 | ||
| Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
| Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
| Induction of CD8+ T cells using heterologous prime-boost immunisation strategies | Q33776098 | ||
| HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy | Q33853859 | ||
| Immunostimulatory DNA sequences necessary for effective intradermal gene immunization | Q34384185 | ||
| Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites | Q34408886 | ||
| Differential requirements for survival and proliferation of CD8 naïve or memory T cells | Q34430192 | ||
| A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. | Q35601931 | ||
| Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? | Q35959154 | ||
| T cell memory is short-lived in the absence of antigen | Q36230537 | ||
| Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen | Q36231954 | ||
| Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity | Q36366362 | ||
| The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection | Q36548993 | ||
| On the role of antigen in maintaining cytotoxic T-cell memory | Q37361402 | ||
| Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy | Q39595379 | ||
| Apoptosis in viral infections | Q40551607 | ||
| Immunological memory and protective immunity: understanding their relation | Q40969823 | ||
| Cytotoxic T-cell memory without antigen | Q41460535 | ||
| Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism | Q41734956 | ||
| The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen | Q42942101 | ||
| Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 | ||
| Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara | Q44138669 | ||
| A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group | Q44174498 | ||
| Linear differentiation of cytotoxic effectors into memory T lymphocytes | Q44659226 | ||
| Persistence of memory CD8 T cells in MHC class I-deficient mice | Q44698642 | ||
| P433 | issue | 6797 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 793-798 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Vaccines against intracellular infections requiring cellular immunity | |
| P478 | volume | 406 |
| Q46242885 | A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates. |
| Q36787928 | A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection |
| Q35122498 | A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses |
| Q52591488 | A Salmonella Typhi ghost induced by the E gene of phage φX174 stimulates dendritic cells and efficiently activates the adaptive immune response. |
| Q37230330 | A comprehensive analysis of LACK (Leishmania homologue of receptors for activated C kinase) in the context of Visceral Leishmaniasis |
| Q42637823 | A gp63 based vaccine candidate against Visceral Leishmaniasis |
| Q34558350 | A mucosal vaccination approach for herpes simplex virus type 2. |
| Q24804936 | A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults |
| Q36371349 | Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein |
| Q35177576 | Adjuvants for vaccines, a quest |
| Q33992101 | Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge |
| Q45233558 | Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers |
| Q44467383 | Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection |
| Q34105274 | Agonistic anti-CD40 enhances the CD8+ T cell response during vesicular stomatitis virus infection |
| Q39187810 | Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection |
| Q57200992 | Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana |
| Q90211678 | An in vitro functional assay to measure the biological activity of TB vaccine candidate H4-IC31 |
| Q36483545 | Antigen delivered by anthrax lethal toxin induces the development of memory CD8+ T cells that can be rapidly boosted and display effector functions |
| Q35773892 | Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells |
| Q35049146 | Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines |
| Q37578971 | Are pregnant women with chronic helminth infections more susceptible to congenital infections? |
| Q36086627 | Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in burmese rhesus macaques. |
| Q81390476 | Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting |
| Q34949279 | Bicistronic DNA vaccines simultaneously encoding HIV, HSV and HPV antigens promote CD8⁺ T cell responses and protective immunity |
| Q40856165 | Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge |
| Q36587103 | Burkholderia vaccines: are we moving forward? |
| Q37333434 | CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans. |
| Q36128896 | Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity |
| Q91644203 | Chimeric Murine Polyomavirus Virus-Like Particles Induce Plasmodium Antigen-Specific CD8+ T Cell and Antibody Responses |
| Q35867557 | Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice |
| Q26823750 | Chlamydia psittaci: update on an underestimated zoonotic agent |
| Q37643904 | Chlamydia trachomatis-infected epithelial cells and fibroblasts retain the ability to express surface-presented major histocompatibility complex class I molecules |
| Q46629754 | Circumvention of MHC class II restriction by genetic immunization |
| Q33746872 | Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses |
| Q27304818 | Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection |
| Q34381599 | Construction of a recombinant-attenuated Salmonella Enteritidis strain secreting Escherichia coli heat-labile enterotoxin B subunit protein and its immunogenicity and protection efficacy against salmonellosis in chickens. |
| Q40107329 | Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine |
| Q36746934 | Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children |
| Q33796005 | Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis |
| Q47851462 | Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells |
| Q40188102 | DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells |
| Q40569363 | DNA immunisation with minimalistic expression constructs. |
| Q39213050 | DNA prime-protein boost strategy with replicase-based DNA vaccine against foot-and-mouth disease in bovine calves |
| Q39455250 | Deletion of the single putative N-glycosylation site of the porcine circovirus type 2 Cap protein enhances specific immune responses by DNA immunisation in mice |
| Q34416167 | Dendritic cell discoveries provide new insight into the cellular immunobiology of DNA vaccines |
| Q36371330 | Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice |
| Q39521650 | Dendritic cells can initiate protective immune responses against malaria. |
| Q39427650 | Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine |
| Q45859155 | Design of magnetic polyplexes taken up efficiently by dendritic cell for enhanced DNA vaccine delivery. |
| Q34631422 | Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach |
| Q34684829 | Differential and site specific impact of B cells in the protective immune response to Mycobacterium tuberculosis in the mouse |
| Q34792987 | Diminished Memory T-Cell Expansion Due to Delayed Kinetics of Antigen Expression by Lentivectors |
| Q40688177 | Efficient uptake and rapid degradation of plasmid DNA by murine dendritic cells via a specific mechanism |
| Q80766949 | Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly |
| Q92890646 | Enterococcus faecium NCIMB 10415 administration improves the intestinal health and immunity in neonatal piglets infected by enterotoxigenic Escherichia coli K88 |
| Q33635680 | Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence |
| Q36375937 | Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine |
| Q34078008 | Evaluation of approaches to identify the targets of cellular immunity on a proteome-wide scale. |
| Q79711919 | Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis |
| Q41702772 | Evaluation of the immune response in Shitou geese (Anser anser domesticus) following immunization with GPV-VP1 DNA-based and live attenuated vaccines |
| Q34691785 | Exploiting dendritic cells to improve vaccine efficacy |
| Q100749460 | Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches |
| Q40069778 | Expression and role of VLA-1 in resident memory CD8 T cell responses to respiratory mucosal viral-vectored immunization against tuberculosis |
| Q64992596 | Gas chromatography-mass spectrometry method for determination of β-propiolactone in human inactivated rabies vaccine and its hydrolysis analysis. |
| Q40588228 | Generation and characterization of P gene-deficient rabies virus |
| Q40212185 | Generation of a safe Salmonella Gallinarum vaccine candidate that secretes an adjuvant protein with immunogenicity and protective efficacy against fowl typhoid. |
| Q35648255 | Genome-derived vaccines |
| Q40051307 | Genome-wide DNA methylation analysis of senescence in repetitively infected memory CTLs DNA methylation analysis of repetitively infected memory CTLs. |
| Q79369214 | Glycyrrhizin inhibits the manifestations of anti-inflammatory responses that appear in association with systemic inflammatory response syndrome (SIRS)-like reactions |
| Q58803575 | Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice |
| Q37116031 | HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase |
| Q38110546 | Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis |
| Q37383963 | How B cells shape the immune response against Mycobacterium tuberculosis |
| Q35592360 | How far have we reached in tuberculosis vaccine development? |
| Q36217237 | Identification and validation of immunogenic potential of India specific HPV-16 variant constructs: In-silico &in-vivo insight to vaccine development |
| Q33293036 | Identification of Eimeria tenella genes encoding for secretory proteins and evaluation of candidates by DNA immunisation studies in chickens |
| Q41470261 | Identification of secreted proteins as novel antigenic vaccine candidates of Haemophilus parasuis serovar 5. |
| Q33847573 | Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda |
| Q28067442 | Immunization Strategies against Piscirickettsia salmonis Infections: Review of Vaccination Approaches and Modalities and Their Associated Immune Response Profiles |
| Q36235860 | Immunization of mice by hollow mesoporous silica nanoparticles as carriers of porcine circovirus type 2 ORF2 protein |
| Q90307153 | Immunoadjuvant Activity of Fucoidans from the Brown Alga Fucus evanescens |
| Q64087564 | Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of |
| Q40572422 | Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c mice |
| Q37866369 | Immunologic considerations for generating memory CD8 T cells through vaccination. |
| Q46858889 | Immunopotentiation of live brucellosis vaccine by adjuvants |
| Q24602785 | Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice |
| Q49161794 | Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial. |
| Q41384167 | Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant |
| Q84002630 | In vitro and in vivo identification of a novel cytotoxic T lymphocyte epitope from Rv3425 of Mycobacterium tuberculosis |
| Q42258180 | In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity |
| Q36751598 | Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivector |
| Q39741627 | Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene |
| Q44341808 | Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex |
| Q47245565 | Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation |
| Q38461061 | Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies |
| Q40749121 | Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice |
| Q80391573 | Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein |
| Q40103816 | Listening to each other: Infectious disease and cancer immunology |
| Q36386097 | Local immunity by tissue-resident CD8(+) memory T cells. |
| Q64886404 | Longitudinal Evaluation of Humoral Immunity and Bacterial and Clinical Parameters Reveals That Antigen-Specific Antibodies Suppress Inflammatory Responses in Active Tuberculosis Patients. |
| Q90301796 | Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation |
| Q37451022 | Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection |
| Q33521186 | Maternal infection with Trypanosoma cruzi and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines |
| Q44880897 | Memory T cells protect chicks from acute infectious bronchitis virus infection |
| Q58109651 | Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant |
| Q45722006 | Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara |
| Q29619125 | Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major |
| Q36370322 | Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines |
| Q64076539 | Oral Vaccination With a Formulation Combining Subolesin With Heat Inactivated Reduces Tick Infestations in Cattle |
| Q41192964 | Oral Vaccination of Channel Catfish against Enteric Septicemia of Catfish Using a Live Attenuated Edwardsiella ictaluri Isolate |
| Q24677367 | PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells |
| Q43678379 | Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen |
| Q35581128 | Progress in the development of an HIV vaccine |
| Q35922431 | Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes. |
| Q34008507 | Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant |
| Q40863426 | Protective Efficacy of an Inactive Vaccine Based on the LY02 Isolate against Acute Haemophilus parasuis Infection in Piglets |
| Q34975686 | Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine |
| Q46610970 | Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL/6 mice |
| Q34007297 | Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis |
| Q53706343 | Protective humoral and CD4+ T cellular immune responses of Staphylococcus aureus vaccine MntC in a murine peritonitis model. |
| Q30416916 | Pushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses |
| Q78593977 | Quantitative analysis of the antigen-specific IFNgamma+ T cell-mediated immune response in conventional outbred pigs: kinetics and duration of the DNA-induced IFNgamma+ CD8+ T cell response |
| Q33850281 | Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen |
| Q59806879 | Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens |
| Q27304664 | Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein Promotes Protective Immune Responses in Mice |
| Q53224717 | Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice. |
| Q92826671 | Reduced Renal Colonization and Enhanced Protection by Leptospiral Factor H Binding Proteins as a Multisubunit Vaccine Against Leptospirosis in Hamsters |
| Q36153446 | Repetitive peptide boosting progressively enhances functional memory CTLs |
| Q41433615 | Robust vaccine formulation produced by assembling a hybrid coating of polyethyleneimine-silica. |
| Q37451253 | Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis |
| Q104286463 | Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial |
| Q40507112 | Salmonella enterica serovar Typhimurium interaction with dendritic cells: impact of the sifA gene |
| Q43648841 | Selection and identification of Singapore grouper iridovirus vaccine candidate antigens using bioinformatics and DNA vaccination |
| Q38273050 | Shaping the CD4+ memory immune response against tuberculosis: the role of antigen persistence, location and multi-functionality. |
| Q43882094 | Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection |
| Q28603191 | Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study |
| Q34762112 | Strategies for designing vaccines eliciting Th1 responses in humans |
| Q57165945 | Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime–boost approach |
| Q27317212 | Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques |
| Q34207642 | TB vaccines: progress and problems. |
| Q46396497 | Testing the immunocompetence handicap hypothesis: Testosterone manipulation does not affect wound healing in male salamanders |
| Q33747338 | The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications |
| Q30155223 | The OmpA family of proteins: roles in bacterial pathogenesis and immunity |
| Q41569795 | The Positive Correlation of the Enhanced Immune Response to PCV2 Subunit Vaccine by Conjugation of Chitosan Oligosaccharide with the Deacetylation Degree |
| Q34988360 | The immunology of susceptibility and resistance to Leishmania major in mice |
| Q35039807 | The role of B cells and humoral immunity in Mycobacterium tuberculosis infection |
| Q86299842 | The role of B cells and humoral immunity in Mycobacterium tuberculosis infection |
| Q35851825 | Therapeutic vaccination against HIV. |
| Q36238083 | Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates |
| Q28472202 | Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors |
| Q34324978 | Towards the rational design of Th1 adjuvants |
| Q58843474 | Trypanosoma cruzi activates cord blood myeloid dendritic cells independently of cell infection |
| Q35039934 | Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis |
| Q27311087 | Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins |
| Q42248079 | Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis |
| Q34398787 | Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria model |
| Q80785089 | Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge |
| Q49033611 | Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination. |
| Q47860399 | Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers |
| Q77797870 | Vaccine safety--vaccine benefits: science and the public's perception |
| Q40470546 | Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity. |
| Q59359933 | Virus-derived immunostimulatory RNA induces type I IFN-dependent antibodies and T-cell responses during vaccination |
| Q33916280 | Whole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response |
| Q42002483 | gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani. |
Search more.